Figure 5 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Figure 5 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

<p>NKCEs override HLA-I inhibitory interactions. Degranulation activity of NK cells (All NK, gating on CD3<sup>−</sup>CD56<sup>+</sup>) and different NK-cell subsets [single (s)KIR2DL1<sup>+</sup>, KIR2DL3<sup>+</sup>/KIR3DL1<sup>+</sup&...

Shranjeno v:

Bibliografske podrobnosti
Glavni avtor:	Natalia Colomar-Carando (14611340) (author)
Drugi avtorji:	Laurent Gauthier (15129623) (author), Pietro Merli (15129626) (author), Fabrizio Loiacono (5306981) (author), Paolo Canevali (332990) (author), Michela Falco (368897) (author), Federica Galaverna (8825531) (author), Benjamin Rossi (15129629) (author), Frédéric Bosco (15129632) (author), Mélody Caratini (15129635) (author), Maria Cristina Mingari (8409327) (author), Franco Locatelli (15127797) (author), Eric Vivier (48284) (author), Raffaella Meazza (7179467) (author), Daniela Pende (15129638) (author)
Izdano:	2025
Teme:	Cancer Immuno-oncology Hematological Cancers Leukemias Immunology NK cells Immunotherapy Stem cell transplantation
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Figure 1 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
od: Natalia Colomar-Carando (14611340)
Izdano: (2025)

Figure 2 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
od: Natalia Colomar-Carando (14611340)
Izdano: (2025)

Figure 3 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
od: Natalia Colomar-Carando (14611340)
Izdano: (2025)

Figure 4 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
od: Natalia Colomar-Carando (14611340)
Izdano: (2025)

Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
od: Amir T. Fathi (15313195)
Izdano: (2025)

Supplemental Figure 2 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
od: Amir T. Fathi (15313195)
Izdano: (2025)

Investigation on the Occurrence of Premature Ovarian Insufficiency after Allogeneic Haematopoietic Stem Cell Transplantation and Prognosis Analysis - a single-center real-world cross-sectional study
od: 辰宇石 (22420348)
Izdano: (2025)

Reducing Anxiety and Improving Adherence in Kidney Transplant Recipients: A Cognitive Behavioral Intervention -Based Approach
od: Chao Zhong (22679885)
Izdano: (2025)

<b>B lymphocytes impede Tregs to erode islet tolerance in Type 1 Diabetes</b>
od: Christopher S. Wilson (22462794)
Izdano: (2025)

Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
od: Wei Liu (20030)
Izdano: (2025)

Supplementary Figure 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
od: Wei Liu (20030)
Izdano: (2025)

Supplementary Figure 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
od: Wei Liu (20030)
Izdano: (2025)

Supplementary Figure 4 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
od: Wei Liu (20030)
Izdano: (2025)

Supplementary Figure 5 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
od: Wei Liu (20030)
Izdano: (2025)

Supplementary Figure 6 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
od: Wei Liu (20030)
Izdano: (2025)

Supplementary Figure7 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
od: Wei Liu (20030)
Izdano: (2025)

Supplementary Table 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
od: Wei Liu (20030)
Izdano: (2025)

Supplementary Table 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
od: Wei Liu (20030)
Izdano: (2025)

Supplementary Table 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
od: Wei Liu (20030)
Izdano: (2025)

Data Sheet 1_Glycocalyx kinetics and injury during liver procurement and transplantation as predictors of early graft dysfunction.docx
od: Nassiba Beghdadi (9577919)
Izdano: (2025)

Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i>-Mutant Clonal Hematopoiesis
od: Rathana Kim (15135915)
Izdano: (2025)

Pearson correlations between willingness to participate in engagement and past participation in engagement.
od: Becca Beets (12878526)
Izdano: (2025)

Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
od: Sushil Kumar (20371917)
Izdano: (2025)

Cerebellar Purkinje cell (PC)-specific amyloid precursor protein (APP) expression modulates motor function.
od: Miao-Jin Ji (22676552)
Izdano: (2025)

A Guide to Creative Engagement in Public Spaces
od: Victoria Foster (21491630)
Izdano: (2025)

Reliability for the five sub-dimensions of past participation in engagement.
od: Becca Beets (12878526)
Izdano: (2025)

Descriptive statistics for five sub-dimensions of engagement activities.
od: Becca Beets (12878526)
Izdano: (2025)

Core Nature restoration
od: Fedorchenko (22513145)
Izdano: (2025)

Results of reliability tests for the five sub-dimensions of engagement activities.
od: Becca Beets (12878526)
Izdano: (2025)

Blog: Engaging with digital platforms for fundraising – a view from Montenegro
od: Milana Čergić (22674940)
Izdano: (2025)

Exogenous amyloid precursor protein (APP) expression restored the defects of the sIPSCs evoked by Nav1.6-mediated Purkenji cell inputs in APP-null mice.
od: Miao-Jin Ji (22676552)
Izdano: (2025)

Comparison of hierarchical classifier performance among four machine learning models for the early-loss, intermediate-loss, and late/no-loss groups.
od: Raiki Yoshimura (22676573)
Izdano: (2025)

Comparison of multi-class classifier performance among four machine learning models for early-loss, intermediate-loss, and late/no-loss groups.
od: Raiki Yoshimura (22676573)
Izdano: (2025)

Comparison of binary classifier performance among four machine learning models for early-loss, intermediate-loss, and late/no-loss groups.
od: Raiki Yoshimura (22676573)
Izdano: (2025)

Comparison of performance of four machine learning models for long-term graft loss prediction.
od: Raiki Yoshimura (22676573)
Izdano: (2025)

Comparison of prediction performance with previously reported metrics.
od: Raiki Yoshimura (22676573)
Izdano: (2025)

Comparison of performance of four machine learning models for early graft loss prediction.
od: Raiki Yoshimura (22676573)
Izdano: (2025)

Predicting stratified groups in the validation cohort: (A) Workflows for the multi-class classification and hierarchical classification models are illustrated.
od: Raiki Yoshimura (22676573)
Izdano: (2025)

Stratification and characterization of groups showing different graft survival: (A) UMAP visualization of the stratified derivation cohort data based on the distance matrix from the RF clustering.
od: Raiki Yoshimura (22676573)
Izdano: (2025)

Prediction of early graft loss at the individual level and identification of crucial factors: (A) Survival curves for all patients who experienced graft loss are plotted.
od: Raiki Yoshimura (22676573)
Izdano: (2025)

Cannot write session to /tmp/vufind_sessions/sess_rgkaegsipjd5127pjvvlri4n7g